Nuclear News on the Newswire

My story: Dennis Mosebey—ANS member since 1981

. . . and today.

Mosebey in 1984 . . .

I graduated from high school in 1969. My yearbook says my career ambition was to be a nuclear physicist. This was inspired by a paperback book I read: Men Who Made a New Physics by Barbara Lovett Cline. I enrolled as a physics student at Susquehanna University that fall and graduated four years later. Many job applications were sent out, but I quickly learned in any branch of physics you needed at least a master’s degree and preferably a Ph.D. So, I applied to the Penn State nuclear engineering program as a master’s degree candidate. This would not be nuclear physics, but it would be close enough. To help with expenses, Penn State had quite a few internships with branches of Westinghouse, and mine was a three-month-long stint that summer at the Liquid Metal Fast Breeder Reactor project at Waltz Mill, Pa. My job was to work on expanding the uranium-238 fast fission cross sections into the 20-MeV range. Of course, I had no idea what a cross section was, but my supervisor, Gene Paik, and my office partners, especially Colin Durston, were immensely helpful.

Go to Article

Fermi America, Texas Tech share vision for massive power and data complex

Texas Tech University and Fermi America shared plans on June 26 to build “the world’s largest advanced energy and artificial intelligence campus” in Amarillo, Texas, near the Pantex nuclear weapons plant. Fermi America is a company cofounded by former Texas governor and energy secretary Rick Perry and his son, Griffin Perry, a cofounder and past senior advisor at Grey Rock Investment Partners. The announcement—a first press release from relative newcomer Fermi America—says the company “proudly answers President Donald J. Trump’s call to deliver global energy and AI dominance.”

Go to Article

The U.S. Million Person Study of Low-Dose-Rate Health Effects

There is a critical knowledge gap regarding the health consequences of exposure to radiation received gradually over time. While there is a plethora of studies on the risks of adverse outcomes from both acute and high-dose exposures, including the landmark study of atomic bomb survivors, these are not characteristic of the chronic exposure to low-dose radiation encountered in occupational and public settings. In addition, smaller cohorts have limited numbers leading to reduced statistical power.

Go to Article

Orano Med expands its Texas Pb-212 R&D center

Orano Group subsidiary Orano Med, a developer of targeted alpha therapies for oncology, inaugurated the expansion of its main research and development center located in Plano, Texas. The facility is used in the development of radiopharmaceuticals and for conducting preclinical research focused on targeted alpha therapies using lead-212, an alpha-emitting radioisotope that has shown promise in treating various types of cancer.

Go to Article

NRC’s David Wright visits the Hill and more NRC news

Wright

The Nuclear Regulatory Commission is in the spotlight today for three very different reasons. First, NRC Chair David Wright was on Capitol Hill yesterday for his renomination hearing in front of the Senate’s Environment and Public Works Committee. Second, the NRC released its updated milestone schedules according to the Nuclear Energy Innovation and Modernization Act (NEIMA) and the executive orders signed by President Trump last month; and third, as reported by Reuters on Tuesday, 28 former NRC officials have condemned the dismissal of Commissioner Hanson earlier this month.

Renomination: EPW Committee chair Sen. Shelley Moore Capito (R., W.Va.) opened the hearing with a statement praising Wright’s experience and emphasized the urgency of stable leadership at the NRC.

“China is executing a rapid build-out of its nuclear industry,” Capito said. “The demand for clean, baseload power is skyrocketing as we position America to win the AI race.”

Go to Article